On September 24, the A Decade of Glory for China's Innovative Drugs ranking list was grandly unveiled at the 2025 China Pharma Decision Makers Summit and the celebration event A Decade of Achievements in China's Innovative Drugs.. Chipscreen Biosciences was awarded the Industry-Leading Biotech Company, and Chiglitazar Sodium (Bilessglu®) was awarded the Industry-Leading Innovative Drug.

The A Decade of Glory for China's Innovative Drugs ranking aims to recognize outstanding companies, institutions, and significant achievements that have delivered exceptional performance over the past decade, made remarkable contributions to the upgrading of China's innovative drug industry, and played a leading role. The ranking features eight award categories, honoring industry leaders across various sectors, including biopharmaceutical parks, investment institutions, CROs, CDMOs, biotech companies, pharmaceutical enterprises, multinational pharmaceutical corporations, and innovative drugs.